|
|
||||||||
Departments of Radiology and Surgery, University of Maryland Medical System, Baltimore, Maryland
Correspondence: For correspondence or reprints contact: Charles C. Chen, MD, Department of Radiology, Saint Francis Medical Center, 530 NE Glen Oak Ave., Peoria, IL 61637.
ABSTRACT
The ability of 99mTc-pertechnetate/sestamibi subtraction, double-phase 99mTc-sestamibi and 99mTc-sestamibi SPECT imaging to localize abnormal parathyroid tissue was compared. Methods: Fifty-five consecutive patients had parathyroid imaging before surgery for hyperparathyroidism. Imaging consisted of 99mTc-pertechnetate pinhole images of the neck followed by 99mTc-sestamibi pinhole images of the neck and parallel-hole images of the neck and chest (early images). Within 2.54.0 hr later pinhole images of the neck, parallel-hole and SPECT images of the neck and chest were obtained (late images). Nodular foci of increased sestamibi activity were considered abnormal. Results: The sensitivity for abnormal parathyroid glands by visual comparison of early images and pertechnetate images was 72%75%, late images and pertechnetate images was 73%78% and double-phase (early and late) sestamibi images was 62%65%; computer subtraction of pertechnetate from early images was 71%74%; and SPECT imaging was 79%. The sensitivity for parathyroid adenomas was 89%98%, while the sensitivity for hyperplastic parathyroid glands was only 47%58%. Conclusion: Late imaging, computer subtraction and SPECT may not be necessary since they provided only marginal improvements on visual comparison of early sestamibi with pertechnetate images. Double-phase sestamibi imaging was less sensitive, so baseline thyroid imaging with pertechnetate is recommended.
Key Words: parathyroid hyperparathyroidism technetium-99m-sestamibi technetium-99m-MIBI
This article has been cited by other articles:
![]() |
H. K. Eslamy and H. A. Ziessman Parathyroid Scintigraphy in Patients with Primary Hyperparathyroidism: 99mTc Sestamibi SPECT and SPECT/CT RadioGraphics, September 1, 2008; 28(5): 1461 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Lavely, S. Goetze, K. P. Friedman, J. P. Leal, Z. Zhang, E. Garret-Mayer, A. P. Dackiw, R. P. Tufano, M. A. Zeiger, and H. A. Ziessman Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-Phase 99mTc-Sestamibi Parathyroid Scintigraphy J. Nucl. Med., July 1, 2007; 48(7): 1084 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hara, T. Takayama, M. Onoguchi, N. Obane, T. Miyati, T. Yoshioka, K. Sakaguchi, and M. Honda Subtraction SPECT for Parathyroid Scintigraphy Based on Maximization of Mutual Information J. Nucl. Med. Technol., June 1, 2007; 35(2): 84 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ruda, B. C. Stack Jr, and C. S. Hollenbeak The Cost-effectiveness of Additional Preoperative Ultrasonography or Sestamibi-SPECT in Patients With Primary Hyperparathyroidism and Negative Findings on Sestamibi Scans Arch Otolaryngol Head Neck Surg, January 1, 2006; 132(1): 46 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spanu, A. Falchi, A. Manca, P. Marongiu, A. Cossu, N. Pisu, F. Chessa, S. Nuvoli, and G. Madeddu The Usefulness of Neck Pinhole SPECT as a Complementary Tool to Planar Scintigraphy in Primary and Secondary Hyperparathyroidism J. Nucl. Med., January 1, 2004; 45(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lorberboym, I. Minski, S. Macadziob, G. Nikolov, and P. Schachter Incremental Diagnostic Value of Preoperative 99mTc-MIBI SPECT in Patients with a Parathyroid Adenoma J. Nucl. Med., June 1, 2003; 44(6): 904 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rink, H.-J. Schroth, L.-H. Holle, and H. Garth Limited Sensitivity of Parathyroid Imaging with 99mTc-Sestamibi/123I Subtraction in an Endemic Goiter Area J. Nucl. Med., September 1, 2002; 43(9): 1175 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Neumann, C. B. Esselstyn Jr., A. Madera, C. O. Wong, and M. Lieber Parathyroid Detection in Secondary Hyperparathyroidism with 123I/99mTc-Sestamibi Subtraction Single Photon Emission Computed Tomography J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3867 - 3871. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |